Macroglossia: Clinical Trials

1 trial for Macroglossia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Macroglossia: new trials by email Literature Review of Macroglossia trials Research Report on Macroglossia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Isatuximab, Laboratory Biomarker Analysis - Amorphous, Eosinophilic, and Acellular Deposit, Constipation
Phase 2CompletedSWOG Cancer Research Network432018-06-062025-09-09

Narrower conditions

Constipation (1)  ·  Diarrhea (1)  ·  Gastrointestinal Hemorrhage (1)  ·  Hepatomegaly (1)  ·  Immunoglobulin Light-chain Amyloidosis (1)  ·  Lymphadenopathy (1)  ·  Nausea (1)  ·  Purpura (1)

Broader conditions

Amyloidosis (1)  ·  Blood Coagulation Disorders (1)  ·  Digestive System Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhage (1)  ·  Hypertrophy (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Liver Diseases (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Metabolic Diseases (1)  ·  Mouth Diseases (1)

Interventions

isatuximab (1)

Sponsors

SWOG Cancer Research Network (1)

Countries

United States (1)

Top investigators

Emma Scott (1)

Results publications

PMID 40925099

NIH funding

U10CA180888 (1)